• PEAK Matrix®
    April 10, 2026

    Healthcare payers and providers are operating under sustained pressure from fragmented engagement ecosystems, rising consumer expectations, and intensifying regulatory and quality mandates. Disconnected clinical, administrative, and customer interaction systems continue to limit end-to-end visibility across member…
  • PEAK Matrix®
    April 15, 2026

    Healthcare providers are navigating sustained financial pressures driven by rising labor costs, reimbursement uncertainty, and increasing patient financial responsibility. In this environment, revenue cycle management has become central to maintaining financial stability and improving cash flow…
  • Provider Compendium
    Nov. 28, 2025

    Everest Group’s Order-to-Cash (O2C) Products – Provider Compendium 2025 provides comprehensive and fact-based snapshots of 16 O2C products and includes insights on the global O2C products market. It examines each product’s features, enhancements, and market adoption…
  • Provider Compendium
    Sep. 30, 2026

    Healthcare providers continue to navigate financial turbulence as patient volumes recover unevenly and margins remain pressured by rising labor costs, high denial rates, increasing patient financial responsibility, and reimbursement uncertainty. These conditions are making revenue cycle…
  • PEAK Matrix®
    Sep. 30, 2025

    Enterprises are increasingly turning to modern Order-to-Cash (O2C) products in response to growing cost pressures, tighter regulations, and the need for improved agility. Once viewed as a back-office finance function, O2C is becoming a strategic enabler…
  • State of the Market
    Feb. 25, 2026

    The clinical development technology market transform as life sciences enterprises increasingly rely on digital and AI-enabled solutions to manage rising costs, complex regulatory demands, and longer development cycles. This State of the Market report outlines how…
  • Tech Launch Perspective
    July 22, 2026

    Life sciences enterprises are moving beyond isolated generative AI pilots toward governed, multi-agent workflows that support clinical, commercial, and real-world activities. This shift is increasing demand for platforms that combine regulatory-grade data governance, enterprise interoperability, scalable…
  • Provider Compendium
    Sep. 16, 2025

    Pharmacovigilance (PV) operations have become a strategic priority for life sciences enterprises facing heightened regulatory scrutiny, evolving safety standards, and growing complexity across global markets. This report provides an in-depth assessment of 12 leading PV service…
  • PEAK Matrix®
    Feb. 19, 2026

    Healthcare payers are navigating volatile medical costs, limited premium growth, and fragmented legacy systems. At the same time, regulatory and quality requirements are intensifying, with the Centers for Medicare and Medicaid Services (CMS) advancing interoperability and…
  • PEAK Matrix®
    July 16, 2025

    In recent years, life sciences enterprises have reprioritized and overhauled their R&D investments. They now focus on streamlining their pipelines and shifting toward new and large molecules. This transformation has compelled aggressive cost containment initiatives, prompting…
  • PEAK Matrix®
    Aug. 26, 2026

    Order-to-Cash (O2C) is moving higher on the CFO agenda as enterprises seek to improve cash predictability, support evolving monetization models, and meet rising expectations for seamless stakeholder experiences. These priorities are accelerating demand for O2C products…
  • PEAK Matrix®
    Aug. 19, 2025

    Clinical Data Management (CDM) is rapidly transforming as life sciences enterprises navigate increasing trial complexity, heightened regulatory scrutiny, and the expansion of decentralized and real-world data sources. CDM now plays a strategic role in enabling faster,…
  • Provider Compendium
    June 26, 2026

    Healthcare payers are operating in an increasingly complex environment shaped by volatile medical costs, constrained premium growth, evolving regulatory requirements, fragmented legacy systems, and continued workforce constraints. These pressures are pushing health plans to move beyond…
  • Provider Compendium
    Feb. 28, 2025

    Decentralized and hybrid designs add more complexity to clinical trials, generating vast data volumes from diverse sources. This complexity creates significant data management challenges. In response, sponsors are adopting unified clinical Data and Analytics (D&A) platforms…
  • Provider Compendium
    Sep. 30, 2025

    In recent years, life sciences enterprises have reoriented their R&D investments, prioritizing pipeline efficiency and a strategic focus on large and novel molecules. This shift has intensified efforts around cost containment and created a stronger need…
  • Provider Compendium
    Nov. 06, 2025

    Clinical Data Management (CDM) operations have become a strategic priority for life sciences enterprises as they face growing trial complexities, expanding data volumes, and the integration of decentralized and real-world data sources. These dynamics are reshaping…
  • PEAK Matrix®
    Nov. 12, 2024

    Due to decentralized and hybrid designs, the growing clinical trial complexity generates vast data volumes from diverse sources and creates significant data management challenges. In response, sponsors are increasingly employing unified clinical data and analytics (D&A)…
  • PEAK Matrix®
    Sep. 01, 2025

    eCOA solutions are transforming clinical trials by enabling accurate, real-time capture of patient, clinician, and caregiver-reported outcomes through smartphones, tablets, web portals, and provisioned devices. These platforms are redefining how clinical trials capture participant-reported data by…
  • Provider Compendium
    Nov. 25, 2025

    Life sciences enterprises are accelerating their shift to modern digital platforms to meet evolving demands for agility, patient-centricity, and regulatory compliance. Traditional ERP and CRM systems are giving way to cloud-based platforms that enable intelligent, connected…
  • PEAK Matrix®
    July 24, 2023

    The pandemic accelerated the need to extract value from data as it led to a substantial increase in data generation from various clinical sources, characterized by high veracity, variety, and volume. As a result, there has…

Items per page